Shai Shimony

1.4k total citations · 2 hit papers
59 papers, 740 citations indexed

About

Shai Shimony is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Shai Shimony has authored 59 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 20 papers in Public Health, Environmental and Occupational Health and 15 papers in Oncology. Recurrent topics in Shai Shimony's work include Acute Myeloid Leukemia Research (28 papers), Acute Lymphoblastic Leukemia research (20 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Shai Shimony is often cited by papers focused on Acute Myeloid Leukemia Research (28 papers), Acute Lymphoblastic Leukemia research (20 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Shai Shimony collaborates with scholars based in Israel, United States and Germany. Shai Shimony's co-authors include Richard M. Stone, Maximilian Stahl, Pia Raanani, Daniel J. DeAngelo, Marlise R. Luskin, Ofir Wolach, Ronit Gurion, Anat Gafter‐Gvili, Donna Neuberg and Moshe Yeshurun and has published in prestigious journals such as Nature, Blood and British Journal of Pharmacology.

In The Last Decade

Shai Shimony

53 papers receiving 736 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and management

2023 215 citations Shai Shimony, Maximilian Stahl et al. American Journal of Hematology profile →
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management

2025 20 citations Shai Shimony, Maximilian Stahl et al. American Journal of Hematology profile →

Peers

Countries citing papers authored by Shai Shimony

Since Specialization

Citations

This map shows the geographic impact of Shai Shimony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shai Shimony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shai Shimony more than expected).

Fields of papers citing papers by Shai Shimony

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shai Shimony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shai Shimony. The network helps show where Shai Shimony may publish in the future.

Co-authorship network of co-authors of Shai Shimony

This figure shows the co-authorship network connecting the top 25 collaborators of Shai Shimony. A scholar is included among the top collaborators of Shai Shimony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shai Shimony. Shai Shimony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Biology and Management of Acute Myeloid Leukemia With Mutated NPM1 2025 ·American Journal of Hematology ·Evan C. Chen, Shai Shimony, Marlise R. Luskin, Richard M. Stone	1
2	Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols 2024 ·Leukemia ·Yannis K. Valtis, Yael Flamand, Shai Shimony, Andrew E. Place, Lewis B. Silverman, Lynda M. Vrooman, Andrew M. Brunner, Stephen E. Sallan, Martha Wadleigh, Richard M. Stone, Daniel J. DeAngelo, Marlise R. Luskin	5
3	Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients 2024 ·Leukemia ·Shai Shimony, Jacqueline S. Garcia, (unknown), Evan C. Chen, Marlise R. Luskin, Maximilian Stahl, Donna Neuberg, Daniel J. DeAngelo, Richard M. Stone, R. Coleman Lindsley	14
4	Organ involvement in adults with BPDCN is associated with sun exposure history, TET2 and RAS mutations, and survival 2024 ·Blood Advances ·Shai Shimony, (unknown), (unknown), Marlise R. Luskin, Donna Neuberg, Nicole R. LeBoeuf, Andrew A. Lane	5
5	Chronic Lymphocytic Leukemia (CLL)-Derived Extracellular Vesicles Educate Endothelial Cells to Become IL-6-Producing, CLL-Supportive Cells 2024 ·Biomedicines ·Orit Uziel, (unknown), (unknown), Einat Beery, (unknown), Meir Lahav, (unknown), (unknown), Roded Sharan, (unknown), Lorenzo Signorini, Shai Shimony, Pia Raanani, (unknown)	3
6	Tri‐ing to decipher trisomy AML 2024 ·British Journal of Haematology ·Shai Shimony, Evan C. Chen	0
7	Acute myeloid leukemia (AML) with chromosome 3 inversion: biology, management, and clinical outcome 2024 ·Leukemia & lymphoma ·(unknown), Jan Philipp Bewersdorf, (unknown), Amer M. Zeidan, Shai Shimony, Maximilian Stahl	1
8	Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML 2024 ·Leukemia ·Shai Shimony, Jan Philipp Bewersdorf, Rory M. Shallis, Yiwen Liu, (unknown), Amer M. Zeidan, Aaron D. Goldberg, Eytan M. Stein, Guido Marcucci, R. Coleman Lindsley, Evan C. Chen, (unknown), Anthony S. Stein, Daniel J. DeAngelo, Donna Neuberg, Richard M. Stone, Brian Ball, Maximilian Stahl	17
9	Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen 2024 ·Blood Cancer Journal ·Shai Shimony, (unknown), Yael Flamand, (unknown), (unknown), Yannis K. Valtis, Andrew E. Place, Lewis B. Silverman, Stephen E. Sallan, Lynda M. Vrooman, Andrew M. Brunner, Donna Neuberg, Ilene Galinsky, Jacqueline S. Garcia, Eric S. Winer, Martha Wadleigh, Richard M. Stone, Jean M. Connors, Daniel J. DeAngelo, Marlise R. Luskin	2
10	Blastic plasmacytoid dendritic cell neoplasm: Extensive disease, Langer lines, and blood burden in a retrospective study of 66 cases 2024 ·Journal of the American Academy of Dermatology ·(unknown), (unknown), Shai Shimony, Ai‐Tram N. Bui, Andrew A. Lane, Nicole R. LeBoeuf	1
11	Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia 2023 ·Leukemia Research ·Maximilian Stahl, (unknown), Yiwen Liu, Eric S. Winer, Jacqueline S. Garcia, Evan C. Chen, Martha Wadleigh, (unknown), R. Coleman Lindsley, Shai Shimony, (unknown), Anne Charles, Daniel J. DeAngelo, Richard M. Stone, Anju Nohria, Marlise R. Luskin	2
12	Prevalence and Clinical Characteristics of Paraproteinemia Associated with Chronic Myeloid Leukemia 2022 ·Acta Haematologica ·(unknown), Adi Shacham Abulafia, Shai Shimony, Oren Pasvolsky, Iuliana Vaxman, (unknown), (unknown), Avi Leader, Pia Raanani	0
13	Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors 2021 ·Journal of Thrombosis and Haemostasis ·(unknown), (unknown), Shai Shimony, (unknown), (unknown), (unknown), (unknown), (unknown), Tzippy Shochat, Galia Spectre, Pia Raanani, Ofer Rotem, Elizabeth Dudnik, Nir Peled, Alona Zer, Avi Leader	54
14	Post-transplantation maintenance with sorafenib or midostaurin for FLT3 positive AML patients – a multicenter retrospective observational study 2021 ·Leukemia & lymphoma ·Shai Shimony, Moshe Yeshurun, Ofir Wolach, Ron Ram, Uri Rozovski, Liat Shargian, (unknown), Odelia Amit, Yael Bar‐On, (unknown), Batia Avni, (unknown), Pia Raanani, Oren Pasvolsky	3
15	Maintenance therapy after allogeneic hematopoietic transplant for acute myeloid leukemia: a systematic review and meta-analysis 2021 ·Acta Oncologica ·Oren Pasvolsky, Shai Shimony, Moshe Yeshurun, Liat Shargian, Ofir Wolach, Pia Raanani, Anat Gafter‐Gvili, Ronit Gurion	12
16	Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission after 5-azacitidine and venetoclax: a multicenter retrospective study 2021 ·Annals of Hematology ·Oren Pasvolsky, Shai Shimony, Ron Ram, Avichai Shimoni, Liat Shargian, Batia Avni, Ofir Wolach, Tzippy Shochat, Ronit Yerushalmi, Odelia Amit, Pia Raanani, Moshe Yeshurun	23
17	Safety and efficacy of blinatumomab: a real world data 2020 ·Annals of Hematology ·Arie Apel, Yishai Ofran, Ofir Wolach, Shai Shimony, Ron Ram, Itai Levi, Miri Zektser, Maya Koren‐Michowitz	21
18	FDG PET/CT as a diagnostic and prognostic tool for the evaluation of marginal zone lymphoma 2019 ·Hematological Oncology ·Iuliana Vaxman, Hanna Bernstine, Geffen Kleinstern, (unknown), Shai Shimony, Liran Domachevsky, Ronit Gurion, David Groshar, Pia Raanani, Anat Gafter‐Gvili	20
19	Incidence, predictors and prognostic implications of dyspnea at admission among acute coronary syndrome patients without heart failure 2019 ·International Journal of Cardiology ·(unknown), Shai Shimony, Gideon Y. Stein, (unknown), Zaza Iakobishvili, Sa’ar Minha, Shmuel Fuchs	4
20	Effects of natural and novel synthetic jasmonates in experimental metastatic melanoma 2007 ·British Journal of Pharmacology ·(unknown), Alina Heyfets, Shai Shimony, Jardena Nordenberg, Yoel Kashman, Eliezer Flescher	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact